Peptide

Taxorest

Also known as

A-19 · A-19 lung bioregulator · lung cytomax · bronchial cytomax · Khavinson lung complex · Taxorest peptide

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

A-19 / Cytomax	An animal-tissue peptide mixture from bronchial tissue, usually discussed as swallowed capsules for breathing comfort and lung support.
Different from lung synthetics	Chonluten and Bronchogen are different peptides. Their injection amounts, response times and results cannot be transferred to Taxorest.

Notes

Taxorest, also called A-19, is an animal-tissue peptide mixture discussed for easier breathing and lung support. Community accounts describe respiratory stacks and comparisons with other lung peptides. They do not establish that Taxorest alone repairs lungs or replaces respiratory treatment.

An extract, rather than one synthetic peptide. The Cytomax name refers to a mixture from bronchial tissue, the lining of the breathing tubes. The familiar form is a swallowed capsule. Chonluten and Bronchogen are different synthetic peptides; their injection amounts and timelines cannot simply be transferred to A-19.

Comparison stories can be mistaken for Taxorest results. The CosmicNootropic poster described breathing and gym improvements with Chonluten and Bronchogen, then proposed Taxorest. The Biohacking question received replies about other compounds. Neither thread supplies an observed Taxorest failure or success, and no Taxorest-specific adverse account was established here. Chonluten: proposed Taxorest sequence (Secondhand community claim · Accessed 2026-09-30) · Lung support: asthma and cardio question (Community discussion · Accessed 2026-09-30)

Source context — Chonluten: proposed Taxorest sequence: Brand-centered subreddit. Author explicitly had not started Taxorest; stated sequence and equivalence claims are speculation, not an observed Taxorest regimen.

Source context — Lung support: asthma and cardio question: Replies concern GHK-Cu and secondhand Chonluten, not Taxorest results. Do not count the same questioner twice.

What people notice

Stairs and breathing	One emphysema account describes easier stairs while crediting Taxorest, NAC and diet after smoking cessation, without a dose or lung-test series.
Stacked respiratory accounts	A former smoker reports easier breathing and roughly half as much residual cough with several products. A preserved X account describes major quality-of-life improvement in a rare lung disease stack.
What those changes mean	These accounts do not isolate Taxorest or establish reversal of lung scarring or emphysema. Questions about months-long benefit are not completed success reports.

Notes

Stairs became easier in one emphysema account. Senior Forums member big-air described needing 5–10 minutes to recover after stairs, later climbing with little difficulty. They credited Taxorest, NAC and diet after stopping smoking. No Taxorest start date, dose or lung-test series was supplied; the later quoted post is the same account. COPD: big-air's Taxorest account (Personal report · Accessed 2026-09-30)

A respiratory stack felt helpful to a former smoker. LongeCity member pure reported easier breathing and roughly halved residual cough while using Taxorest, Ventfort and Vladonix capsules, Chonluten between courses, and other organ products. Supplier guidance shaped the stack. This does not isolate Taxorest. Peptide Bioregulators (Russian): pure's respiratory stack (Personal report · Accessed 2026-09-30)

A rare-lung-disease story remains one stacked report. The preserved X note describes a substantial quality-of-life improvement with Taxorest, Ventfort and Vladonix over two years. It includes no breathing-test results. Its useful course history remains a personal claim, with no freshly inspected X post available.

Easier breathing, less cough or more comfortable activity. These are the practical changes in lung-stack discussions. Taxorest is often one part of several interventions, so a better day does not reveal which ingredient helped. Describing comfort also does not show that scarring or emphysema has reversed. Asthma peptide: Taxorest lasting-effect question (Secondhand community claim · Accessed 2026-09-30)

A lasting effect after another lung peptide. A Reddit questioner said Chonluten helped a little and repeated the idea that Taxorest would extend that benefit for months. They were asking whether it worked, rather than reporting that it had. The proposed lasting effect remains unconfirmed. Asthma peptide: Taxorest lasting-effect question (Secondhand community claim · Accessed 2026-09-30)

Source context — COPD: big-air's Taxorest account: Self-reported emphysema; smoking cessation, diet, NAC and an unnamed additional peptide confound attribution. #18 quotes the original and is not a second responder.

Source context — Peptide Bioregulators (Russian): pure's respiratory stack: Supplier-informed stacked capsules plus Chonluten and other organ products. No Taxorest-only results. The nonresponse in #40 does not identify purchased compounds and is not Taxorest-specific.

Source context — Asthma peptide: Taxorest lasting-effect question: Poster reports prior Chonluten use and asks about Taxorest; prolonged effect is hearsay, not completed Taxorest use. Same poster as Lung support.

Doses people talk about

Commercial oral chart	10 mg complex per capsule; 1–2 capsules once or twice daily gives chart endpoints of 10–40 mg/day. A 0.2 g whole-capsule mass is not 200 mg active peptide.
Fractional-capsule report	About one-fifth capsule under the tongue several times daily in a blogger's changing Taxorest/Chonluten use. No dependable Taxorest-only milligram amount follows.
Originating add-on report	One capsule twice daily for 30 days alongside usual chronic-bronchitis care in the originating brochure, not an independently established regimen.

Notes

Oral chart: 10 mg complex per capsule; 1–2 capsules per use, once or twice daily. A promotional Reddit guide repeats this with meals: 10–20 mg per administration, with chart endpoints of 10–40 mg daily. Its 0.2 g serving is whole-capsule mass, not 200 mg active peptide. This is a commercial chart, not an independently established community dose. Taxorest A-19 guide circulated in brand subreddit (Community guide · Accessed 2026-09-30)

A fractional-capsule account has no dependable mg conversion. One blogger reports about one-fifth capsule under the tongue several times daily, across roughly six months of Taxorest/Chonluten use. Product switching prevents assigning this to Taxorest alone. Healing with Peptides: lungs section (Personal report · Accessed 2026-09-30)

The originating report studied an add-on. A 2011 brochure reports chronic-bronchitis care plus one capsule twice daily for 30 days and improved breathing measures, with 4–6-month repeats. It does not establish replication, human half-life or a regimen. Originating-group clinical brochure: Taxorest (Official context · Accessed 2026-09-30)

Source context — Taxorest A-19 guide circulated in brand subreddit: Commercial promotional repost with discount code; product chart, not personal use or safety evidence. Capsule package length is arithmetic, not measured benefit duration.

Source context — Healing with Peptides: lungs section: Commercial links/coupons; switched products, KPV co-use and subjective 30% estimate. Fractional-capsule amount is not an identified Taxorest mg dose. Same author ecosystem as Diary of Recovery; one account.

Source context — Originating-group clinical brochure: Taxorest: Original originating-group report hosted by distributor. No transparent randomized/blinded method, independent replication or concentration-time study in inspected section. This is not an independent trial publication.

Half-life, onset & duration

Felt onset	No reliable Taxorest-specific clock: accounts combine or switch respiratory products without a dated Taxorest-only symptom change.
Felt duration	Months-long carryover is repeated as a claim, not measured in a completed Taxorest-only account. A 30-day course does not establish post-stop benefit duration.
Half-life	No dependable human number in these records. A mixture does not supply a single component-clearance value.

Notes

No reliable Taxorest-specific onset clock. The records combine respiratory products or switch between them without a dated Taxorest-only start and symptom change. Neither a course checkpoint nor another lung peptide's timeline establishes A-19 onset.

Months of benefit is a claim, not a measured window. The Chonluten discussion repeats a months-long carryover idea without a completed Taxorest account. A 30-day capsule course describes time taking a product; it does not establish how long breathing feels different after stopping. Asthma peptide: Taxorest lasting-effect question (Secondhand community claim · Accessed 2026-09-30) · Taxorest A-19 guide circulated in brand subreddit (Community guide · Accessed 2026-09-30)

No dependable human half-life is available in these discussions. Taxorest is a peptide mixture, so no single component-clearance number follows from its name. The preserved timing record supplies no measured human value. Repeat calendars and claims of lasting effects do not measure how quickly its components leave the body. Asthma peptide: Taxorest lasting-effect question (Secondhand community claim · Accessed 2026-09-30)

Cycles people discuss

Commercial calendars	Charts describe 10–30-day supplies and repeats every 3–6 months. Proposed lung-peptide sequences with two-week gaps were plans made before trying Taxorest.
Preserved long account	Three courses yearly for two years with Ventfort and Vladonix. It is one stacked-use history, without a measured single-dose or off-course window.

Notes

Commercial schedules and user calendars differ. The circulated Reddit chart describes 10–30-day supplies and repeats every 3–6 months. One brand-subreddit author proposed separate lung-peptide courses, two-week gaps and a sequence repeated 2–3 times yearly before trying Taxorest. Proposed calendars are not demonstrated recovery cycles. Taxorest A-19 guide circulated in brand subreddit (Community guide · Accessed 2026-09-30) · Chonluten: proposed Taxorest sequence (Secondhand community claim · Accessed 2026-09-30)

Three courses per year appears in an actual preserved account. The longer X story used Taxorest with vessel and thymus products. It supports a report of repeated stacked use, not a general repeat recommendation or daily indefinite use.

Two years describes repeated use, not one lasting dose. The preserved X account describes three courses yearly for two years alongside Ventfort and Vladonix. That history cannot identify a single-dose effect or a symptom-free interval after each course.

Stacks

Ventfort and Vladonix	These accompany Taxorest in the preserved X report and a LongeCity respiratory account; the latter also used Chonluten between courses and other organ products.
Other reported companions	NAC and diet accompany the emphysema story. A commercially linked blogger switches lung products and also credits KPV, preventing Taxorest-only credit.

Notes

Ventfort + Vladonix: The 2-year X trio. [anecdote]

The recovery blogger preferred another formulation. The same author began with Taxorest, preferred Chonluten's taste and apparent speed, later favored LunGuard, and also credited KPV. Their roughly 30% improvement estimate and later tiny maintenance amounts describe changing products, not measured Taxorest benefit. The blogs contain commercial links. Healing with Peptides: lungs section (Personal report · Accessed 2026-09-30) · Peptide Diary Pages: Day 14 lungs (Personal report · Accessed 2026-09-30)

Source context — Peptide Diary Pages: Day 14 lungs: Same recovery-author source family as recoveringkids.com. Product switching and commercial links; Day 14 is an editorial entry number, not treatment onset.

Watch for

Respiratory care	The accounts do not justify replacing inhalers, oxygen or specialist medicines. Continuing severe breathing difficulty or failed rescue medicine needs emergency help.
Animal origin and tolerance	The brochure excludes pregnancy, breastfeeding and ingredient sensitivity. No reliable adverse-effect frequency or long-term safety is established here.
Product form	Capsules are not an inhaled rescue product. Natural-origin claims do not resolve identity, absorption or medicine interactions.

Notes

Breathing trouble still needs established care. Avoiding inhalers is part of some forum narratives, not evidence that Taxorest can replace them, oxygen or specialist medicines. For an asthma attack with continuing severe breathing difficulty or medicines failing to relieve symptoms, NHLBI advises emergency help. Asthma: Asthma Attack (Official context · Accessed 2026-09-30)

Animal origin and tolerance matter. The originating brochure excludes pregnancy, breastfeeding and sensitivity to ingredients. Promotional claims of no side effects do not establish safety, medication compatibility or long-term tolerance; the inspected accounts provide no reliable adverse-effect frequency. Originating-group clinical brochure: Taxorest (Official context · Accessed 2026-09-30) · Taxorest A-19 guide circulated in brand subreddit (Community guide · Accessed 2026-09-30)

Capsules are not an inhaled rescue product. There is no reconstitution recipe for the capsule. Storage follows its formulation's label. “Natural” does not resolve identity, absorption or interactions.

Source context — Asthma: Asthma Attack: General asthma guidance; supplies emergency caution, no evidence about Taxorest.

Full notes

What Taxorest actually is

An extract, rather than one synthetic peptide. The Cytomax name refers to a mixture from bronchial tissue, the lining of the breathing tubes. The familiar form is a swallowed capsule. Chonluten and Bronchogen are different synthetic peptides; their injection amounts and timelines cannot simply be transferred to A-19. Community
Lung support is the goal people describe. Asthma discussions ask about breathing comfort and better cardio. Former smokers compare lung peptides hoping to regain easier activity. An account about another peptide is useful comparison context, but it is not a Taxorest outcome. Reddit r/Biohacking Reddit r/CosmicNootropic

What people hope to notice

Easier breathing, less cough or more comfortable activity. These are the practical changes in lung-stack discussions. Taxorest is often one part of several interventions, so a better day does not reveal which ingredient helped. Describing comfort also does not show that scarring or emphysema has reversed. Community Reddit r/BodyHackGuide
A lasting effect after another lung peptide. A Reddit questioner said Chonluten helped a little and repeated the idea that Taxorest would extend that benefit for months. They were asking whether it worked, rather than reporting that it had. The proposed lasting effect remains unconfirmed. Reddit r/BodyHackGuide

Doses people discuss

Oral chart: 10 mg complex per capsule; 1–2 capsules per use, once or twice daily. A promotional Reddit guide repeats this with meals: 10–20 mg per administration, with chart endpoints of 10–40 mg daily. Its 0.2 g serving is whole-capsule mass, not 200 mg active peptide. This is a commercial chart, not an independently established community dose. Community guide
A fractional-capsule account has no dependable mg conversion. One blogger reports about one-fifth capsule under the tongue several times daily, across roughly six months of Taxorest/Chonluten use. Product switching prevents assigning this to Taxorest alone. Personal report
Chonluten injection amounts belong to Chonluten. A Reddit author discussed 1 mg daily for 20 days before proposing Taxorest later. They explicitly had not started Taxorest. That injection number is not an A-19 capsule dose, and their claim that routes are equally absorbed is unsupported by that account. Reddit r/CosmicNootropic

Half-life

No dependable human half-life is available in these discussions. Taxorest is a peptide mixture, so no single component-clearance number follows from its name. The preserved timing record supplies no measured human value. Repeat calendars and claims of lasting effects do not measure how quickly its components leave the body. Community Reddit r/BodyHackGuide

Onset: when a change might be noticed

No reliable Taxorest-specific onset clock. The records combine respiratory products or switch between them without a dated Taxorest-only start and symptom change. Neither a course checkpoint nor another lung peptide's timeline establishes A-19 onset. Community

Duration: how long a benefit lasts

Months of benefit is a claim, not a measured window. The Chonluten discussion repeats a months-long carryover idea without a completed Taxorest account. A 30-day capsule course describes time taking a product; it does not establish how long breathing feels different after stopping. Reddit r/BodyHackGuide Community guide
Two years describes repeated use, not one lasting dose. The preserved X account describes three courses yearly for two years alongside Ventfort and Vladonix. That history cannot identify a single-dose effect or a symptom-free interval after each course. Community

Cycles and repeat-course talk

Commercial schedules and user calendars differ. The circulated Reddit chart describes 10–30-day supplies and repeats every 3–6 months. One brand-subreddit author proposed separate lung-peptide courses, two-week gaps and a sequence repeated 2–3 times yearly before trying Taxorest. Proposed calendars are not demonstrated recovery cycles. Community guide Reddit r/CosmicNootropic
Three courses per year appears in an actual preserved account. The longer X story used Taxorest with vessel and thymus products. It supports a report of repeated stacked use, not a general repeat recommendation or daily indefinite use. Community

Good to know

Breathing trouble still needs established care. Avoiding inhalers is part of some forum narratives, not evidence that Taxorest can replace them, oxygen or specialist medicines. For an asthma attack with continuing severe breathing difficulty or medicines failing to relieve symptoms, NHLBI advises emergency help. Community Official context
Animal origin and tolerance matter. The originating brochure excludes pregnancy, breastfeeding and sensitivity to ingredients. Promotional claims of no side effects do not establish safety, medication compatibility or long-term tolerance; the inspected accounts provide no reliable adverse-effect frequency. Official context Community guide Community
Capsules are not an inhaled rescue product. There is no reconstitution recipe for the capsule. Storage follows its formulation's label. “Natural” does not resolve identity, absorption or interactions. Community Community

Community: what the accounts actually describe

Stairs became easier in one emphysema account. Senior Forums member big-air described needing 5–10 minutes to recover after stairs, later climbing with little difficulty. They credited Taxorest, NAC and diet after stopping smoking. No Taxorest start date, dose or lung-test series was supplied; the later quoted post is the same account. Personal report
A respiratory stack felt helpful to a former smoker. LongeCity member pure reported easier breathing and roughly halved residual cough while using Taxorest, Ventfort and Vladonix capsules, Chonluten between courses, and other organ products. Supplier guidance shaped the stack. This does not isolate Taxorest. Personal report
The recovery blogger preferred another formulation. The same author began with Taxorest, preferred Chonluten's taste and apparent speed, later favored LunGuard, and also credited KPV. Their roughly 30% improvement estimate and later tiny maintenance amounts describe changing products, not measured Taxorest benefit. The blogs contain commercial links. Personal report Personal report
A rare-lung-disease story remains one stacked report. The preserved X note describes a substantial quality-of-life improvement with Taxorest, Ventfort and Vladonix over two years. It includes no breathing-test results. Its useful course history remains a personal claim, with no freshly inspected X post available. Community
Comparison stories can be mistaken for Taxorest results. The CosmicNootropic poster described breathing and gym improvements with Chonluten and Bronchogen, then proposed Taxorest. The Biohacking question received replies about other compounds. Neither thread supplies an observed Taxorest failure or success, and no Taxorest-specific adverse account was established here. Reddit r/CosmicNootropic Reddit r/Biohacking

Supporting clinical context

The originating report studied an add-on. A 2011 brochure reports chronic-bronchitis care plus one capsule twice daily for 30 days and improved breathing measures, with 4–6-month repeats. It does not establish replication, human half-life or a regimen. Official context